IL6 and hepatocellular carcinoma: Previous studies observed a cytokine-mediated upregulation of CD55 and CD59 expression in human hepatoma cells in tumors mediated via pro-inflammatory cytokines such as tumor necrosis factor-alpha, IL-1 beta, and IL-6 [38].